ZCM
SCMP

Zebra Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Zebra Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,268
Closed -$237K – 304
2016
Q3 		$237K Sell
19,268
-1,184
-6% -$14K 0.07% 260
2016
Q2 		$224K Sell
20,452
-199
-1% -$2.23K 0.08% 256
2016
Q1 		$226K Buy
20,651
+2,931
+17% +$37K 0.09% 244
2015
Q4 		$306K Buy
+17,720
New +$318K 0.17% 211

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

Zebra Capital Management's SCMP Position: Q4 2016 in Review

Zebra Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2016, closing a stake of 19,268 shares — an estimated $237K sold.

Zebra Capital Management first reported a position in SCMP in Q4 2015 and held it in 4 quarters. The position peaked at $306K in Q4 2015. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

  • Zebra Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Zebra Capital Management sold 19,268 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $237K.
  • Zebra Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2015 and held it in 4 quarters.
  • Zebra Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $306K in Q4 2015.
  • 165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on Zebra Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.